Article info
Commentary
General medicine
Erenumab is effective in reducing migraine frequency and improving physical functioning
- Correspondence to Prof. Paolo Martelletti, Universita degli Studi di Roma La Sapienza; Paolo.Martelletti{at}uniroma1.it
Citation
Erenumab is effective in reducing migraine frequency and improving physical functioning
Publication history
- Accepted July 24, 2018
- First published August 14, 2018.
Online issue publication
March 25, 2019
Article Versions
- Previous version (14 August 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.